Edwards Lifesciences Corporation (EW)
NYSE · Healthcare
Edwards Lifesciences Corporation Operating Income 2008–2025
Edwards Lifesciences Corporation annual/quarterly operating income history and growth rate from 2016 to 2026. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- Edwards Lifesciences Corporation operating income for the quarter ending March 31, 2026 was 477.6 M, a 20.97% increase year-over-year.
- Edwards Lifesciences Corporation operating income for the twelve months ending March 31, 2026 was 1.6 B, a 11.08% increase year-over-year.
- Edwards Lifesciences Corporation annual operating income for 2025 was 1.3 B, a 8.30% decrease from 2024.
- Edwards Lifesciences Corporation annual operating income for 2024 was 1.4 B, a 5.33% increase from 2023.
- Edwards Lifesciences Corporation annual operating income for 2023 was 1.3 B, a 12.65% decrease from 2022.
- Edwards Lifesciences Corporation annual operating income for 2022 was 1.5 B.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Edwards Lifesciences Corporation Operating Income — FAQ
Edwards Lifesciences Corporation (EW) operating income over the last 18 years — annual and quarterly figures with year-over-year growth and charts.
What is Edwards Lifesciences Corporation's operating income?
Edwards Lifesciences Corporation (EW) reported operating income of $1.26B for fiscal 2025.
Where can I see EW's operating income history?
The chart and table above show Edwards Lifesciences Corporation's operating income by year and by quarter, including the growth rate.